Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
letter
. 2017 Jul 22;216(4):504–506. doi: 10.1093/infdis/jix345

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?

Charles J Woodrow 1,2,, Caterina Fanello 1,2
PMCID: PMC5853314  PMID: 28931242

To the Editor—Parr et al report that Plasmodium falciparum parasites with deletion of the pfhrp2 gene can be found in children across all provinces of the Democratic Republic of Congo [1]. It is possible to differentiate gene deletion from other causes of a negative P. falciparum histidine-rich protein 2 (PfHRP2)–based rapid diagnostic test via a series of investigations [2, 3], starting with positive microscopic identification of P. falciparum, a straightforward way of minimizing at the outset the chance that the gene cannot be detected simply because of low levels of DNA [4]. Parr et al used many of these recommended steps, and the work was clearly undertaken to a high technical standard, but a distinct feature of the study was that the diagnosis of P. falciparum was determined by real-time polymerase chain reaction (PCR) detection of pfldh, a relatively sensitive approach designed to capture all pfhrp2-deleted parasites. The article comes to a confident conclusion that the pfhrp2-negative PCR results represent gene deletion rather than insufficient DNA.

Was this confidence justified? The answer, in our view, is a clear “no.” Unsurprisingly, a large proportion (90%) of the “pfhrp2-deleted” samples were negative on microscopy. In a set of samples where parasitemia is generally below the level of microscopic detection, successful PCR amplification of a control gene does not guarantee that another gene will be robustly amplified from the same sample. Borderline DNA concentrations will cause stochastic failure of individual PCR reactions, so samples negative by PCR for pfhrp2 but positive for other genes and, hence, fulfilling the study’s criteria for “pfhrp2 deletion,” will be inevitable simply because of the number of samples studied.

The potential for overcalling “deletions” gets even worse if any of the positive control PCR reactions are more sensitive than the test reactions. No data on relative sensitivity of the pfhrp2 and control gene reactions were provided (in fact, optimal conditions were explored during the course of the study). However, there is evidence for differential sensitivity of the 2 pfhrp2 PCR reactions. Of the 91 samples positive for only 1 of the 2 pfhrp2 sequences (calculated from supplementary data), most (80) were positive at exon 1/2, with 11 positive at exon 2. The obvious explanation for this, with DNA limiting, is that the exon 1/2 PCR had greater sensitivity: it involved nested primers and a 308-bp amplicon whereas the PCR for exon 2 involved a single pair of primers and a longer amplicon (Table 1), both factors associated with reduced PCR efficiency [5]. Instead, it is simply assumed that all these isolates represent partial pfhrp2 deletions, despite the absence of reports of such parasites in large surveys [6, 7].

Table 1.

Characteristics of Polymerase Chain Reaction Assays Used in the Study of Parr et al

Sequence, Section Length in Genome (Outer Primers) Polymerase Chain Reaction Type
pfhrp2, exon 1/2 308 Nested
pfhrp2, exon 2 842 Single pair of primers
pfhrp3, exon 1/2 301 Single pair of primers
pfhrp3, exon 2 719 Heminested
β-tubulin 77 Single pair of primers
pfldh a Not applicable Real-time

aPositive result used as entry criterion to study.

In addition, there was an intrinsic bias in study design. For a sample to avoid the classification “pfhrp2 deleted,” both pfhrp2 sections had to be amplified. But subsequent “confirmation” of sufficient DNA required that only 1 of 3 control PCR sequences be amplified (2 sections of pfhrp3 and β-tubulin). The authors state that of “149 pfhrp2-deleted P. falciparum isolates, only 5 (3.4%) had co-existing complete pfhrp3 deletions,” but this is the wrong comparison—to interpret the data properly, we need to know how many samples had negative results for either of the pfhrp3 sections (the standard applied for pfhrp2). Although this was not directly determined (control PCR assays were undertaken serially until a positive was obtained), the supplementary data show that the first pfhrp3 PCR failed in 73 cases, again indicating broadly low levels of DNA.

The finding that a subset of samples with “pfhrp2 deletion” had a higher proportion of PCR failures at 2 neighboring microsatellite markers is offered as further evidence for gene deletion. Again, the evidence that this was not simply due to low DNA concentrations is not compelling. Markers were approximately evenly amplified in control samples, but these are likely to have had substantially higher levels of DNA. The lower DNA levels that were certainly present in the pfhrp2-negative samples could have exposed lower PCR efficiency at 2 particular markers. Notably, these markers are on the opposite side of the pfhrp2 gene compared with markers absent in pfhrp2-deleted parasites from Latin America [8].

In summary, the concern that many, and possibly all, of the “deletion” samples are just samples with low levels of DNA is never satisfactorily dispelled. This is a much more plausible explanation for their ubiquitous distribution across the country. For these reasons, calls for alternatives to PfHRP2 as a diagnostic antigen in this region are not yet indicated.

Note

Potential conflicts of interest.  Both authors: No reported conflicts of interest. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1. Parr JB, Verity R, Doctor SM et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey [manuscript published online ahead of print 14 November 2016]. J Infect Dis 2016; 216:36–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Cheng Q, Gatton ML, Barnwell J et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J 2014; 13:283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. Geneva, Switzerland: WHO, 2016. [Google Scholar]
  • 4. Laban NM, Kobayashi T, Hamapumbu H et al. ; Southern Africa International Centers of Excellence for Malaria Research Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination. Malar J 2015; 14:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Mitsuhashi M. Technical report: part 2. Basic requirements for designing optimal PCR primers. J Clin Lab Anal 1996; 10:285–93. [DOI] [PubMed] [Google Scholar]
  • 6. Baker J, Ho MF, Pelecanos A et al. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J 2010; 9:129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Deme AB, Park DJ, Bei AK et al. Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests. Malar J 2014; 13:34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Gamboa D, Ho MF, Bendezu J et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 2010; 5:e8091. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES